Alyeska Investment Group’s Genocea Biosciences, Inc. GNCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-128,203
Closed -$347K 1032
2021
Q1
$347K Hold
128,203
﹤0.01% 676
2020
Q4
$310K Sell
128,203
-1,026
-0.8% -$2.48K ﹤0.01% 464
2020
Q3
$296K Sell
129,229
-13,292
-9% -$30.4K ﹤0.01% 433
2020
Q2
$328K Sell
142,521
-108,316
-43% -$249K 0.01% 428
2020
Q1
$431K Sell
250,837
-40,166
-14% -$69K 0.01% 314
2019
Q4
$602K Buy
291,003
+1,104
+0.4% +$2.28K 0.01% 319
2019
Q3
$841K Sell
289,899
-6,163
-2% -$17.9K 0.01% 305
2019
Q2
$1.16M Buy
+296,062
New +$1.16M 0.02% 329
2019
Q1
Hold
0
458
2018
Q4
Hold
0
493
2018
Q3
Sell
-200,386
Closed -$1.37M 542
2018
Q2
$1.37M Sell
200,386
-28,965
-13% -$198K 0.01% 352
2018
Q1
$1.93M Buy
+229,351
New +$1.93M 0.02% 321
2017
Q2
Sell
-27,868
Closed -$1.36M 574
2017
Q1
$1.36M Sell
27,868
-328
-1% -$16K 0.01% 405
2016
Q4
$929K Buy
28,196
+225
+0.8% +$7.41K 0.01% 412
2016
Q3
$1.15M Buy
27,971
+1,113
+4% +$45.6K 0.01% 400
2016
Q2
$881K Buy
26,858
+545
+2% +$17.9K 0.01% 386
2016
Q1
$1.63M Buy
26,313
+5,831
+28% +$361K 0.02% 338
2015
Q4
$864K Sell
20,482
-2,289
-10% -$96.6K 0.01% 339
2015
Q3
$1.25M Buy
22,771
+19,971
+713% +$1.09M 0.01% 364
2015
Q2
$308K Sell
2,800
-9,828
-78% -$1.08M ﹤0.01% 445
2015
Q1
$1.2M Buy
12,628
+9,614
+319% +$912K 0.02% 397
2014
Q4
$169K Sell
3,014
-111
-4% -$6.22K ﹤0.01% 447
2014
Q3
$226K Buy
+3,125
New +$226K ﹤0.01% 347